West Virginia

This data set provides the Estimated numbers of new cancer cases and deaths in 2023. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. 

Note: Effective September 27, 2023, this dataset will no longer be updated.  This dataset shows health conditions and contributing causes mentioned in conjunction with deaths involving coronavirus disease 2019 (COVID-19).   Number of conditions reported in this table are tabulated from deaths received and coded as of the date of analysis and do not represent all deaths that occurred in that period. Data during this period are incomplete because of the lag in time between when the death occurred and when the death certificate is completed, submitted to NCHS and processed for reporting purposes. This delay can range from 1 week to 8 weeks or more. Conditions contributing to the death were identified using the International Classification of Diseases, Tenth Revision (ICD-10). Deaths involving more than one condition (e.g., deaths involving both diabetes and respiratory arrest) were counted in both totals. To avoid counting the same death multiple times, the numbers for different conditions should not be summated. Deaths with confirmed or presumed COVID-19, coded to ICD–10 code U07.1  

Data cited at: COVID-19 Vaccine Projections https://covid19-projections.com/path-to-herd-immunity/

Deaths involving coronavirus disease 2019 (COVID-19), pneumonia, and influenza reported to NCHS by race, age, and state.   Number of deaths reported in this dataset are the total number of deaths received and coded as of the date of analysis, and do not represent all deaths that occurred in that period. Data during this period are incomplete because of the lag in time between when the death occurred and when the death certificate is completed, submitted to NCHS and processed for reporting purposes. This delay can range from 1 week to 8 weeks or more.

Data cited at: Rt.live-https://rt.live/ These are up-to-date values for Rt, a key measure of how fast the virus is growing. It’s the average number of people who become infected by an infectious person. If Rt is above 1.0, the virus will spread quickly. When Rt is below 1.0, the virus will stop spreading. The reason historical values change is that source is not producing a single point each day, but rather a single curve. One of the constraints of the model is that this curve be connected and smooth. So, if new data suggests that R~t~ should be higher, it will pull up previous values so that the newest point is connected. Imagine a rope lying on the ground. If you pick up the end of that rope, the rope needs to slope up to your hand. The same thing is roughly happening with the model. If all of a sudden a testing center releases far more tests than were expected, the R~t~ curve increases which drags up previous values of R~t~. Since case data is staggered in its arrival, a bunch of new cases will sometimes rewrite its view of history given the new data. 

Estimates of excess deaths can provide information about the burden of mortality potentially related to COVID-19, beyond the number of deaths that are directly attributed to COVID-19. Excess deaths are typically defined as the difference between observed numbers of deaths and expected numbers. This visualization provides weekly data on excess deaths by jurisdiction of occurrence. Counts of deaths in more recent weeks are compared with historical trends to determine whether the number of deaths is significantly higher than expected. Estimates of excess deaths can be calculated in a variety of ways, and will vary depending on the methodology and assumptions about how many deaths are expected to occur. Estimates of excess deaths presented in this web page were calculated using Farrington surveillance algorithms (1). For each jurisdiction, a model is used to generate a set of expected counts, and the upper bound of the 95% Confidence Intervals (95% CI) of these expected counts is used as a threshold to estimate excess deaths. Observed counts are compared to these upper bound estimates to determine whether a significant increase in deaths has occurred. Provisional counts are weighted to account for potential under reporting in the most recent weeks. However, data for the most recent week(s) are still likely to be incomplete. Only about 60% of deaths are reported within 10 days of the date of death, and there is considerable variation by jurisdiction.

Disconnected youth, also referred to as opportunity youth, are teenagers and young adults between the ages of 16 and 24 who are neither in school nor working Research reveals that being disconnected as a young person has long-term consequences; it’s associated with lower earnings, less education, worse health, and even less happiness in later adulthood. The duration i.e. how long a young person is disconnected also matters, with longer spells of disconnection associated with worse outcomes. This dataset shows the impact of Covid-19 on disconnected youth rate in the USA.

Data cited at: Prof.Prof. Lauren Gardner; Center for Systems Science and Engineering at John Hopkins University, blog Post -  https://systems.jhu.edu/research/public-health/ncov/   On December 31, 2019, the World Health Organization (WHO) was informed of an outbreak of “pneumonia of unknown cause” detected in Wuhan City, Hubei Province, China – the seventh-largest city in China with 11 million residents. As of February 04, 2020, there are over 24,502 cases confirmed globally, including cases in at least 30 regions in China and 30 countries.  Interests: In-Market Segments Knoema All Users   Knoema modified the original dataset to include calculations per million.   https://knoema.com/WBPEP2018Oct https://knoema.com/USICUBDS2020 https://knoema.com/NBSCN_P_A_A0301 https://knoema.com/IMFIFSS2017Nov https://knoema.com/AUDSS2019 https://knoema.com/UNAIDSS2017 https://knoema.com/UNCTADPOPOCT2019Nov https://knoema.com/WHOWSS2018 https://knoema.com/KPMGDHC2019

NCHS - Leading Causes of Death: United States This dataset presents the age-adjusted death rates for the 10 leading causes of death in the United States beginning in 1999. Data are based on information from all resident death certificates filed in the 50 states and the District of Columbia using demographic and medical characteristics. Age-adjusted death rates (per 100,000 population) are based on the 2000 U.S. standard population. Populations used for computing death rates after 2010 are postcensal estimates based on the 2010 census, estimated as of July 1, 2010. Rates for census years are based on populations enumerated in the corresponding censuses. Rates for non-census years before 2010 are revised using updated intercensal population estimates and may differ from rates previously published. Causes of death classified by the International Classification of Diseases, Tenth Revision (ICD–10) are ranked according to the number of deaths assigned to rankable causes. Cause of death statistics are based on the underlying cause of death. 

(CDC ID's: y6uv-t34t ,7pb7-w9us ,93k9-hy54) NNDSS - Table II. Lyme disease to Meningococcal - 2016. In this Table, provisional* cases of selected notifiable diseases (1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data. Data on United States exclude counts from US territories. Note: These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. Footnotes: C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable. -: No reported cases. N: Not reportable. NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. * Case counts for reporting year 2015 and 2016 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions. Data for meningococcal disease, invasive caused by serogroups ACWY; serogroup B; other serogroup; and unknown serogroup are available in Table I.

The Access Ranking indicates how much access to mental health care exists within a state. The access measures include access to insurance, access to treatment, quality and cost of insurance, access to special education, and workforce availability. A high Access Ranking indicates that a state provides relatively more access to insurance and mental health treatment.

 Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to e National Notifiable Diseases Surveillance System (NNDSS), if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly asnumbered tables  TRANSLATE with xEnglishArabicHebrewPolishBulgarianHindiPortugueseCatalanHmong DawRomanianChinese SimplifiedHungarianRussianChinese TraditionalIndonesianSlovakCzechItalianSlovenianDanishJapaneseSpanishDutchKlingonSwedishEnglishKoreanThaiEstonianLatvianTurkishFinnishLithuanianUkrainianFrenchMalayUrduGermanMalteseVietnameseGreekNorwegianWelshHaitian CreolePersian  TRANSLATE with COPY THE URL BELOW BackEMBED THE SNIPPET BELOW IN YOUR SITEEnable collaborative features and customize widget: Bing Webmaster PortalBack

Table 2o - Typhoid fever; Vancomycin-intermediate Staphylococcus aureus; Vancomycin-resistant Staphylococcus aureus; Varicella morbidity; Varicella mortality; Vibriosis; Suggested Citation:  Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System, 2018 Annual Tables of Infectious Disease Data.  Atlanta, GA. CDC Division of Health Informatics and Surveillance, 2019.  Available at: https://www.cdc.gov/nndss/infectious-tables.html, https://www.cdc.gov/nndss/infectious-tables.html.

(CDC ID's: s5s8-d82d ,4y34-2pku) NNDSS - Table II. Babesiosis to Campylobacteriosis - 2016. In this Table, provisional* cases of selected notifiable diseases (1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data. Data on United States exclude counts from US territories. Note: These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. Footnotes: C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable. -: No reported cases. N: Not reportable. NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. * Case counts for reporting years 2015 and 2016 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions.

(CDC ID's: 9ix3-ryt6 ,mpdg-hf57 ,afja-b25e) NNDSS - Table II. Giardiasis to Haemophilus influenza - 2016. In this Table, provisional* cases of selected notifiable diseases (1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data. Data on United States exclude counts from US territories. Note: These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. Footnotes: C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable. -: No reported cases. N: Not reportable. NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. * Case counts for reporting year 2015 and 2016 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions. Data for H. influenzae (age <5 years for serotype b, nonserotype b, and unknown serotype) are available in Table I.

NNDSS - Table II. Salmonellosis to Shigellosis - 2014.In this Table, all conditions with a 5-year average annual national total of more than or equals 1,000 cases but less than or equals 10,000 cases will be displayed ( 1,000 and _ 10,000). The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data. Data on United States exclude counts from US territories. Note:These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. Footnotes:C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable. -: No reported cases. N: Not reportable. NN: Not Nationally Notifiable Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. * Case counts for reporting years 2013 and 2014 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. Includes E. coli O157:H7; Shiga toxin positive, serogroup non-O157; and Shiga toxin positive, not serogrouped.More information on NNDSS is available at http://wwwn.cdc.gov/nndss/.

These are weekly cases of selected infectious national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables. Cases reported by state health departments to CDC for weekly publication are subject to ongoing revision of information and delayed reporting. Therefore, numbers listed in later weeks may reflect changes made to these counts as additional information becomes available. Case counts in the tables are presented as published each week.  Note- https://wonder.cdc.gov/nndss/static/2021/31/2021-31-table1ii.html https://wonder.cdc.gov/nndss/static/2021/31/2021-31-table1kk.html  https://wonder.cdc.gov/nndss/static/2021/31/2021-31-table1ll.html   

Data cited at: AllClear.App-https://home.allclear.app/  

Deaths involving coronavirus disease 2019 (COVID-19), pneumonia and influenza reported to NCHS by place of death and state, United States.

Deaths involving coronavirus disease 2019 (COVID-19), pneumonia, and influenza reported to NCHS by sex and age group and state.   Number of deaths reported in this table are the total number of deaths received and coded as of the date of analysis, and do not represent all deaths that occurred in that period. Data during this period are incomplete because of the lag in time between when the death occurred and when the death certificate is completed, submitted to NCHS and processed for reporting purposes. This delay can range from 1 week to 8 weeks or more.

Provisional count of deaths involving coronavirus disease 2019 (COVID-19) by United States county.   Deaths with confirmed or presumed COVID-19, coded to ICD–10 code U07.1. Counties included in this table have 10 or more COVID-19 deaths at the time of analysis. Number of deaths reported in this table are the total number of deaths received and coded as of the date of analysis and do not represent all deaths that occurred in that period. Data during this period are incomplete because of the lag in time between when the death occurred and when the death certificate is completed, submitted to NCHS and processed for reporting purposes.

This data file contains the following indicators that can be used to illustrate potential differences in the burden of deaths due to COVID-19 according to race and ethnicity: •Count of COVID-19 deaths: Number of deaths due to COVID-19 reported for each race and Hispanic origin group •Distribution of COVID-19 deaths (%): Deaths for each group as a percent of the total number of COVID-19 deaths reported •Unweighted distribution of population (%): Population of each group as a percent of the total population •Weighted distribution of population (%): Population of each group as percent of the total population after accounting for how the race and Hispanic origin population is distributed in relation to the geographic areas impacted by COVID-19

In the United States, the seasonality of respiratory syncytial virus (RSV) has traditionally been defined on the basis of weeks during which antigen-based tests detect RSV in >10% of specimens. Because molecular testing has become more widely used, we explored the extent of polymerase chain reaction (PCR)–based RSV testing and its impact on determining the seasonality of RSV.

Reporting of new Aggregate Case and Death Count data was discontinued on May 11, 2023, with the expiration of the COVID-19 public health emergency declaration. According to the source, this dataset will receive a final update on June 1, 2023, to reconcile historical data.

These are  weekly  cases of selected infectious national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the US territories are collated and published weekly as numbered tables. Cases reported by state health departments to CDC for weekly publication are subject to the ongoing revision of information and delayed reporting. Therefore, numbers listed in later weeks may reflect changes made to these counts as additional information becomes available.    TRANSLATE with xEnglishArabicHebrewPolishBulgarianHindiPortugueseCatalanHmong DawRomanianChinese SimplifiedHungarianRussianChinese TraditionalIndonesianSlovakCzechItalianSlovenianDanishJapaneseSpanishDutchKlingonSwedishEnglishKoreanThaiEstonianLatvianTurkishFinnishLithuanianUkrainianFrenchMalayUrduGermanMalteseVietnameseGreekNorwegianWelshHaitian CreolePersian  TRANSLATE with COPY THE URL BELOW BackEMBED THE SNIPPET BELOW IN YOUR SITEEnable collaborative features and customize widget: Bing Webmaster PortalBack

Avian influenza is caused by influenza Type A virus (influenza A). Avian-origin influenza viruses are broadly categorized based on a combination of two groups of proteins on the surface of the influenza A virus: hemagglutinin or “H” proteins, of which there are 16 (H1-H16), and neuraminidase or “N” proteins, of which there are 9 (N1-N9). Many different combinations of “H” and “N” proteins are possible. Each combination is considered a different subtype, and related viruses within a subtype may be referred to as a lineage. Avian influenza viruses are classified as either “low pathogenic” or “highly pathogenic” based on their genetic features and the severity of the disease they cause in poultry. Most viruses are of low pathogenicity, meaning that they causes no signs or only minor clinical signs of infection in poultry.

Data cited at:  Ahmad FB, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. 2020. Designed by LM Rossen, A Lipphardt, FB Ahmad, JM Keralis, and Y Chong: National Center for Health Statistics. This data contains provisional counts for drug overdose deaths based on a current flow of mortality data in the National Vital Statistics System. Counts for the most recent final annual data are provided for comparison. National provisional counts include deaths occurring within the 50 states and the District of Columbia as of the date specified and may not include all deaths that occurred during a given time period. Provisional counts are often incomplete and causes of death may be pending investigation (see Technical notes) resulting in an underestimate relative to final counts. To address this, methods were developed to adjust provisional counts for reporting delays by generating a set of predicted provisional counts (see Technical notes). Starting in June 2018, this monthly data release will include both reported and predicted provisional counts.

Data cited at: Ahmad FB, Bastian B. Quarterly provisional estimates for selected indicators of mortality, 2018-Quarter 3, 2019. National Center for Health Statistics. National Vital Statistics System, Vital Statistics Rapid Release Program. 2020. Provisional estimates of death rates. Estimates are presented for each of the 15 leading causes of death plus estimates for deaths attributed to drug overdose, falls (for persons aged 65 and over), human immunodeficiency virus (HIV) disease, homicide, and firearms-related deaths.

Note: Effective September 27, 2023, this dataset will no longer be updated. Provisional counts of deaths by the week the deaths occurred, by state of occurrence, and by select underlying causes of death. The dataset also includes weekly provisional counts of death for COVID-19, coded to ICD-10 code U07.1 as an underlying or multiple cause of death.